Shikiar Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Shikiar Asset Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-15,600	Closed	-$2.81M	–	104
2017 Q3	$2.81M	Sell	15,600 -22,000	-59%	-$3.07M	1.22%	29
2017 Q2	$3.9M	Sell	37,600 -1,000	-3%	-$81.6K	1.68%	23
2017 Q1	$3.03M	Sell	38,600 -8,000	-17%	-$495K	1.37%	29
2016 Q4	$2.09M	Buy	46,600 +7,500	+19%	+$368K	0.92%	32
2016 Q3	$2.18M	Sell	39,100 -400	-1%	-$22.3K	0.97%	33
2016 Q2	$1.98M	Buy	39,500 +3,000	+8%	+$147K	0.88%	33
2016 Q1	$1.68M	Buy	36,500 +4,500	+14%	+$218K	0.77%	33
2015 Q4	$1.97M	Hold	32,000	–	–	0.96%	29
2015 Q3	$1.78M	Hold	32,000	–	–	0.92%	30
2015 Q2	$1.95M	Sell	32,000 -10,000	-24%	-$571K	0.89%	30
2015 Q1	$2.42M	Buy	42,000 +15,000	+56%	+$1.01M	1.05%	29
2014 Q4	$1.56M	Buy	27,000 +2,000	+8%	+$84.2K	0.73%	39
2014 Q3	$712K	Buy	+25,000	New	+$619K	0.3%	61

Shikiar Asset Management's KITE Position: Q4 2017 in Review

Shikiar Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 15,600 shares — an estimated $2.81M sold.

Shikiar Asset Management first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $3.9M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Shikiar Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Shikiar Asset Management sold 15,600 Kite Pharma, Inc. shares in Q4 2017, an estimated $2.81M.
Shikiar Asset Management first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
Shikiar Asset Management's Kite Pharma, Inc. position peaked at $3.9M in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Shikiar Asset Management's 13F filing for Q4 2017, filed 26 Jan 2018.